Toshitaka Nagao

14PUBLICATIONS
67CO-AUTHORS
Molecular targetsPredictive and prognostic markersSolid tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Tumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Jul 31, 2026
Biomarker-Driven Initial Systemic Therapy Enabling Curative-Intent Treatment in Non-Metastatic Unresectable Salivary Duct Carcinoma: A Multi-Institutional Retrospective Study.

|Apr 27, 2026
Personalized Prediction of Postoperative Recurrence in Lung Squamous Cell Carcinoma: Integrating AI-Based Nuclear Morphometry and Clinical Data.

|Apr 25, 2026
Establishment of Salivary Gland Tumors Arising in Salivary Gland-Specific EWSR1::ATF1 Transgenic Mice.

|Oct 30, 2025
One of the binding proteins for administered amyloid-β appears to be anti-Aβ IgG antibody in amyloid plaques.

Reisuke H Takahashi, Mayumi Yokotsuka, Ayako Nakamura

|Aug 30, 2025
CRTC1::MAML2-Positive Hidradenoma With Sebaceous Differentiation.

Megumi Aoki, Keisuke Goto, Kazuyasu Fujii

|Jul 23, 2024
The clinicopathological and prognostic significance of autonomic nerves in salivary duct carcinoma.

Manami Kajiwara, Hideaki Takahashi, Masato Nakaguro

Pageof 3

Frequent Collaborators

6 joint publications

Yuichiro Tada

3 joint publications

Masato Nakaguro

2 joint publications

Daisuke Yunaiyama

2 joint publications

Daisuke Kawakita